We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Inflammatory Cytokine Levels Predict Patient Outcomes After Traumatic Injury

By LabMedica International staff writers
Posted on 09 Nov 2021
Print article
Image: Crystal structure of interleukin-6 (IL-6) (Photo courtesy of Wikimedia Commons)
Image: Crystal structure of interleukin-6 (IL-6) (Photo courtesy of Wikimedia Commons)
Measurement of the inflammatory cytokines interleukin-6 (IL-6) and interleukin-8 (IL-8) can be used to predict patient outcomes after traumatic injury.

Cytokines are peptides, which are important in cell signaling but cannot cross the lipid bilayer of cells to enter the cytoplasm. Cytokines have been shown to be involved in autocrine, paracrine, and endocrine signaling as immuno-modulating agents. They act through cell surface receptors and are especially important in the immune system where they modulate the balance between humoral and cell-based immune responses and regulate the maturation, growth, and responsiveness of particular cell populations.

Traumatic injury is the leading cause of mortality in patients under the age of 50. It is associated with a complex inflammatory response involving hormonal, immunologic, and metabolic mediators. The marked elevation of cytokines and inflammatory mediators subsequently correlates with the development of post-traumatic complications.

Investigators at the University of Kentucky (Lexington, USA) sought to determine whether elevated cytokine levels provided a predictive value for orthopedic trauma patients. For this study they measured IL-6, IL-8, IL-10, and migration inhibitory factor levels in samples obtained from 58 patients with an average age of 40 years who had experienced severe bone, joint, and muscle trauma. Six of the patients (10%) suffered pulmonary complications and five (9%) had acute kidney injury.

Results revealed that addition of IL-6 levels to baseline models significantly improved prediction of pulmonary complication and hospital length of stay. The addition of IL-8 significantly improved the prediction of acute kidney injury. The addition of post-injury IL-6 level to the baseline New Injury Severity Score (NISS) model was better able to predict the occurrence of pulmonary complications as well as prolonged ICU and hospital length of stay.

“This is the first time we have combined parameters of external anatomic injury (NISS) with parameters of the internal physiologic response to injury (cytokines) to determine trauma patient outcomes,” said first author Dr. Arun Aneja, assistant professor of orthopedics at the University of Kentucky.

The study was published in the November 2, 2021, online edition of the Journal of Orthopaedic Research.

Related Links:
University of Kentucky

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
New
Automated Biochemistry Analyzer
AutoChem B861
New
Treponema Pallidum Test
ZEUS IFA Fluorescent Treponemal Antibody-Absorption (FTA-ABS) Test System

Print article

Channels

Immunology

view channel
Image: The discovery of biomarkers could improve endometrial cancer treatment (Photo courtesy of Mount Sinai)

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.